Genotoxic and cytotoxic effects of the novel immunosuppressive agent 3-[(1-methyl-4-nitro-¹H-imidazol-5-yl)thio]-4-methyl-1,2,4-triazole (MNITMT) on mouse bone marrow cells

References

• Abderrahman SM. 1997. Effect of Peganum harmala extract on root tips of Allium cepa. Cytobios. 90(362–363):171–174.
   PubMedGoogle Scholar
• Abderrahman SM. 2004. Mitodepressive effect of Rubia cordifolia extract on the bone marrow cells of mice. Cytologia. 69(3):307–311.
   Google Scholar
• Al-Ahdal MN, McGarry TJ, Hannan MA. 1988. Cytotoxicity of khat (Catha edulis) extract on cultured mammalian cells: effects on macromolecule biosynthesis. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 204(2):317–322.
   PubMed Web of Science ®Google Scholar
• Alexander S, Dowling D. 2005. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine. Internal Medicine Journal. 35(9):570–571.
   PubMed Web of Science ®Google Scholar
• Al-Safi S, Hassan M, Tashtoush B. 2003. Comparison between the effects of azathioprine and its novel non-mercaptopurine analog on antibody response in rabbits. Polish Journal of Pharmacology. 55:239–243.
   PubMedGoogle Scholar
• Bakare AA, Adeyemi AO, Adeyemi A, Alabi OA, Osibanjo O. 2012. Cytogenotoxic effects of electronic waste leachate in Allium cepa. Caryologia. 65(2):94–100.
   Web of Science ®Google Scholar
• Baszczynski CL, Walden DB, Atkinson BG. 1980. CYCLOHEXIMIDE-induced nuclear alterations in maize root tips. Canadian Journal of Genetics and Cytology. 22(3):319–331.
   Google Scholar
• Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. 1993. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut. 34(8):1081–1085.
   PubMed Web of Science ®Google Scholar
• Crawford DJK, Maddocks JL, Jones DN, Szawlowski P. 1996. Rational design of novel immunosuppressive drugs: Analogues of azathioprine lacking the 6-mercaptopurine substituent retain or have enhanced immunosuppressive effects. Journal of Medicinal Chemistry. 39(14):2690–2695.
   PubMedGoogle Scholar
• Danesi R, Del Tacca M. 2004. Hematologic toxicity of immunosuppressive treatment. Transplantation Proceedings. 36(3):703–704.
   PubMedGoogle Scholar
• Erskine, IA, Mackay, JM, Fox, DP.1984. Monitoring patients on long-term drug therapy for genotoxic effects. Basic Life Sci. 29(Pt B):895–905.
   Google Scholar
• Fraser AG, Orchard TR, Jewell DP. 2002. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 50(4):485–489.
   PubMed Web of Science ®Google Scholar
• Frescura VD-S, Laughinghouse HD, Tedesco SB. 2012. Antiproliferative effect of the tree and medicinal species Luehea divaricata on the Allium Cepa cell cycle. Caryologia. 65(1):27–33.
   Web of Science ®Google Scholar
• Gearry RB, Barclay ML. 2005. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 20(8):1149–1157.
   PubMed Web of Science ®Google Scholar
• Kabarity A. 1980. Mitodepressive effect of khat extract in the meristematic region of Allium cepa root tips. Cytologia. 45:733–738.
   Web of Science ®Google Scholar
• Kermani S, Karbalaie K, Madani SH, Jahangirnejad AA, Eslaminejad MB, Nasr-Esfahani MH, Baharvand H. 2008. Effect of lead on proliferation and neural differentiation of mouse bone marrow-mesenchymal stem cells. Toxicology in Vitro. 22(4):995–1001.
   PubMed Web of Science ®Google Scholar
• Kerstens PJSM, Stolk JN, De Abreu RA, Lambooy LHJ, Van Putte LBAD, Boerbooms AAMT. 1995. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis & Rheumatism. 38(1):142–145.
   PubMedGoogle Scholar
• Kurtoglu EL, Yuksel S. 2012. Genotoxic effects of tacrolimus on human lymphocyte cells. Russ J Genet. 48(6):651–655.
   Google Scholar
• Luke CA, Tice RR. 1989. Effect of processing time on the quality of mouse bone-marrow metaphase preparations. Mutation Research Letters. 227(1):59–62.
   Google Scholar
• MacPhee IAM, Bradley JA, Briggs JD, Junor BJR, MacPherson SG, McMillan MA, Rodger RSC, Watson MA. 1998. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation. Transplantation. 66(9):1186–1192.
   PubMedGoogle Scholar
• Marder W, McCune WJ. 2004. Advances in immunosuppressive drug therapy for use in autoimmune disease and systemic vasculitis. Semin Respir Crit Care Med. 25(5):581–594.
   PubMedGoogle Scholar
• Marder W, McCune WJ. 2007. Advances in immunosuppressive therapy. Semin Respir Crit Care Med. 28(4):398–417.
   PubMedGoogle Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods. 65(1–2):55–63.
   PubMed Web of Science ®Google Scholar
• Nagafuchi K, Miyazaki K. 1991. Modulation of genotoxicity of azathioprine by intracellular glutathione in hepatocytes. Journal of Cancer Research and Clinical Oncology. 117(4):321–325.
   PubMedGoogle Scholar
• Nath A, Berger J. 2012. Complications of immunosuppressive/immunomodulatory therapy in neurological diseases. Current Treatment Options in Neurology. 14(3):241–255.
   PubMedGoogle Scholar
• Oliveira VD, Zankl H, Rath T. 2004. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Exp Clin Transplant. 2(2):273–279.
   PubMedGoogle Scholar
• Omari Y, Shuraideh Z, Abderrahman S. 1996. Mitodepressive effect of Khat (Catha edulis) on the bone marrow of mice. Biomedical Letters. 54:69–72.
   Google Scholar
• Patel AA, Swerlick RA, McCall CO. 2006. Azathioprine in dermatology: The past, the present, and the future. Journal of the American Academy of Dermatology. 55(3):369–389.
   PubMed Web of Science ®Google Scholar
• Pollak R, Nishikawa RA, Mozes MF, Jonasson O. 1980. Azathioprine-induced leukopenia clinical significance in renal transplantation. Journal of Surgical Research. 29(3):258–264.
   PubMedGoogle Scholar
• Rath T, Oliveira-Frick V. 2009. Mutagenicity of immunosuppressive medications among renal transplant recipients. American Journal of Nephrology. 30(6):514–520.
   PubMedGoogle Scholar
• Rossi AM, Romano M, Zaccaro L, Pulci R, Salmona M. 1987. DNA synthesis, mitotic index, drug-metabolising systems and cytogenetic analysis in regenerating rat liver: Comparison with bone marrow test after in vivo treatment with cyclophosphamide. Mutat Res. 182(2):75–82.
   PubMed Web of Science ®Google Scholar
• Schmid W. 1975. The micronucleus test. Mutation Research. 31(1):9–15.
   PubMed Web of Science ®Google Scholar
• Seehy M, Badr E, Hafez A. 1989. Genotoxicity of pesticides. Egypt J Genetics Cytol. 18:59–76.
   Google Scholar
• Tjio JH, Whang J. 1962. Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicine administration. Biotechnic & Histochemistry. 37(1):17–20.
   Google Scholar
• Tumah H, Al-Safi S, Abdul-Razzak K. 2006. Biochemical, cytotoxic of a novel non-mercaptopurine immunosuppressant. Acta Pharmaceutica Sinica. 48:109–119.
   Google Scholar
• Weersma RK, Peters FTM, Oostenbrug LE, van den Berg AP, van Haastert M, Ploeg RJ, Posthumus MD, Homan van der Heide JJ, Jansen PLM, van Dullemen HM. 2004. Increased incidence of azathioprine-induced pancreatitis in Crohn’s disease compared with other diseases. Alimentary Pharmacology & Therapeutics. 20(8):843–850.
   PubMed Web of Science ®Google Scholar